KKR to buy Envision Healthcare for $9.9 bln

KKR agreed to buy Envision Healthcare for $9.9 billion, including debt. KKR is buying all of Envision’s outstanding stock for $46 a share. The $9.9 billion deal means Envision is selling for a 10.9x trailing 12 months Adjusted EBITDA. Envision is a U.S. physician services provider.

11 June 2018•8 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles